Previous Article | Next Article 
Infection and Immunity, March 2001, p. 1635-1642, Vol. 69, No. 3
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.3.1635-1642.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Cryptosporidium parvum-Specific Mucosal
Immune Response in C57BL/6 Neonatal and Gamma Interferon-Deficient
Mice: Role of Tumor Necrosis Factor Alpha in Protection
Sonia
Lacroix,*
Roselyne
Mancassola,
Muriel
Naciri, and
Fabrice
Laurent
Laboratoire de Protozoologie, Unité de
Pathologie Aviaire et de Parasitologie, INRA de Tours, 37380 Nouzilly,
France
Received 24 July 2000/Returned for modification 30 August
2000/Accepted 12 December 2000
 |
ABSTRACT |
Both neonatal and C57BL/6 gamma interferon (IFN-
) knockout
(C57BL/6-GKO) mice are susceptible to Cryptosporidium
parvum, but the course of infection is different. Neonatal mice
are able to clear the parasite within 3 weeks, whereas C57BL/6-GKO
mice, depending on age, die rapidly or remain chronically infected. The
mechanism by which IFN-
leads to a protective immunity is yet poorly
understood. In order to investigate the effect of IFN-
on other
cytokines expressed in the intestinal mucosa during C. parvum infection, we studied cytokine mRNA expression in the
neonates and GKO (neonatal and adult) mice by quantitative reverse
transcription-PCR (RT-PCR) at 4 and 9 days after infection. IFN-
mRNA levels were quickly and strongly up-regulated in the mucosa of
neonatal mice. In GKO mice, the Th1-type response was dramatically
altered during the infection, whereas the mRNA expression levels of the
Th2-type cytokines interleukin 4 (IL-4) and IL-10 were increased in
both mouse models. In the absence of IFN-
, the adult knockout mice up-regulated the mRNA levels of inflammatory cytokines, such as IL-1
, IL-6, and granulocyte-macrophage colony-stimulating factor, in
the mucosa, but not tumor necrosis factor alpha (TNF-
), whereas all
these cytokines were up-regulated in the infected neonatal mice.
Further experiments indicated that injections of TNF-
into GKO adult
mice significantly reduced oocyst shedding. The results of the present
study indicate that the resolution of infection is dependent on the
expression of Th1-type cytokines in the mucosa of C57BL/6 mice and that
TNF-
may participate in the control of parasite development.
 |
INTRODUCTION |
Cryptosporidium parvum is
an obligate intracellular protozoan parasite that infects intestinal
epithelial cells of humans and various other mammals. C. parvum causes protracted diarrhea in young and immunodeficient
individuals and can lead to death for AIDS patients. Cryptosporidiosis
is frequent in young farm animals and has economic and environmental
consequences. In immunocompetent hosts, the disease is self-limited,
suggesting a major role for host defense factors in controlling the infection.
Most of the studies of experimental cryptosporidiosis have been
performed with rodents whose immune systems were impaired, e.g.,
neonatal mice (14, 25, 35), rats immunosuppressed with
dexamethasone (27), or congenitally mutated nude
(21, 23) and SCID mice (17, 34). More recent
studies have used mice with targeted mutations for the genes of major
histocompatibility complex class II (1), CD40, CD40L
(7), or gamma interferon (IFN-
) (33, 38).
The key role of IFN-
in resistance to C. parvum infection
initially demonstrated with antibody depletion was confirmed more
recently with IFN-
knockout mice (GKO) (6, 33, 34).
However, the mechanisms whereby IFN-
intervenes in the clearance of
C. parvum are still not well understood. Some possibilities,
not mutually exclusive, include a direct toxic effect of IFN-
on the
parasite or the infected cells or the induction of other cytokines that
can be toxic for the parasite or of chemoattractants for immune cells.
Mead and You reported that susceptible BALB/c-GKO mice recover from
infection whereas C57BL/6-GKO mice remain chronically infected
(24), suggesting that other immune components related to
the genetic background of the mice play a role in the susceptibility of
mice to C. parvum infection.
To determine what IFN-
-dependent components of the immune response
could be involved in the clearance of infection, we compared differential cytokine expression in a healing neonatal mouse model and
in a nonhealing mouse model (neonates and adults) of the same genetic background that was deficient in IFN-
. The cytokine mRNA levels were measured by quantitative reverse transcription-PCR (RT-PCR)
in the intestinal mucosa, at the site where parasites are actively
multiplying. In this study, we report that the mRNA for both Th1- and
Th2-type cytokines was up-regulated during C. parvum
infection and that Th1 cytokines play a major role in the resolution of
infection in the C57BL/6 genetic background. The overexpression of
tumor necrosis factor alpha (TNF-
) observed during infection in
neonatal mice was absent in GKO adult mice. This prompted us to explore
the role of TNF-
in protection against C. parvum in a
model devoid of IFN-
. Intraperitoneal injections of TNF-
during
the first days of the infection resulted in a significant reduction in
oocyst shedding, suggesting that TNF-
can take part in protective
immunity against C. parvum.
 |
MATERIALS AND METHODS |
Mice.
C57BL/6J-Ifgtml and wild-type
mice were purchased from The Jackson Laboratory (Bar Harbor, Maine).
The dams with 1- to 2-day-old litters and the adults were housed
individually in cages under pathogen-free conditions. In another
experiment, 1-day-old GKO neonates were cross-fostered onto normal
C57BL/6 mothers. Food and water were available ad libitum. For RT-PCR
analysis, 3-day-old GKO and wild-type neonatal mice and 6- or
7-week-old GKO mice were inoculated with 106 oocysts of
C. parvum by the oral route. For TNF-
experiments, 10-week-old GKO mice were inoculated with 105 oocysts and
received repeated intraperitoneal injections of murine TNF-
(6.5 µg/kg of body weight) at days 0, 1, 2, and 4 after infection.
Parasite.
C. parvum oocysts were initially
isolated from the feces of an infected child (3) and were
maintained by regular passages in newborn calves. Fecal samples were
stored in 2.5% potassium dichromate at 4°C until use. C. parvum oocysts, isolated from feces by filtration and diethyl
ether sedimentation, were treated with 1.25% sodium hypochlorite,
washed, and stored until use at 4°C in phosphate-buffered saline (pH
7.4) containing 50 U of penicillin G/ml and 0.25 mg of amphotericin
B/ml. Oocysts were less than 2 months old when used as an inoculum.
Intestinal and fecal C. parvum oocyst
determination.
The level of infection in individual neonatal mice
was assessed by the number of oocysts in the intestinal content. Since infection is not always spread homogeneously along the intestine, the
whole intestines were removed from neonatal mice. They were individually homogenized in 1 ml of water with an Ultra-turax, and
oocyst quantification was performed in Sheather's solution on a Thoma cell.
Adult GKO mice were housed individually on a grating, and the
numerations of daily shed oocysts were performed. Feces were filtered
successively through two sieves of porosities of 425 and 100 µm.
After centrifugation, the pellets were weighed. A part of each pellet
was resuspended, and the oocysts were counted in the Sheather's
solution on a Thoma cell.
RNA extraction.
Mice were killed at 4 and 9 days of
infection, and ilea were removed. Peyer's patches were removed from
ilea of adult mice before mRNA extraction processing. For the neonatal
mice, controls were killed at identical ages. In order that the immune
response in the upper layer of the infected mucosa might be studied,
the ilea were not crushed but were split lengthwise and shaken in TRIzol (Gibco-BRL Life Technologies, Cergy Pontoise, France). After 5 min of incubation, ilea were removed and TRIzol solutions were
centrifuged for 5 min at 8,000 × g to eliminate
debris. The supernatants were stored at
70°C until further
processing. RNAs were extracted according to the manufacturer's
instructions and were quantified by measuring the optical density at
260 nm. RNA quality was estimated with agarose gel electrophoresis
using ethidium bromide for staining.
Analysis of cytokine mRNA levels by reverse
transcription-PCR.
One microgram of total RNA was reverse
transcribed using oligo(dT) primers and Moloney murine leukemia virus
reverse transcriptase, according to the manufacturer's instructions
(Eurogentec, Angers, France). Ten percent of the synthesized cDNA was
then subjected to PCR amplification (total volume of reaction mixture,
25 µl). Ten microliters of each RT-PCR mixture was electrophoresed on a 2% agarose gel. mRNA expression levels were quantified by
competitive RT-PCR as described previously (16). Briefly,
the standard RNA for
-actin, IFN-
, interleukin 4 (IL-4), IL-6,
IL-10, IL-12p40, inducible nitric oxide synthase (iNOS), TNF-
, and
granulocyte-macrophage colony-stimulating factor (GM-CSF) obtained
after in vitro transcription of the different plasmids pMCQ1, -2, -3, and -4 (9) carries primer binding sites identical with
those used to amplify target RNA. A similar plasmid was constructed for
quantification of iNOS and IL-1
(F. Laurent and S. Lacroix,
unpublished data). The distances between specific 5' and 3' primer
sequences and, therefore, the sizes of PCR amplification products
differ for standard and target RNAs. Serial threefold dilutions of
standard RNA molecules were mixed with 1 µg of total sample RNA and
reverse transcribed. PCR products were separated on a 2% agarose gel
and visualized by ethidium bromide staining, and band intensities were
quantitated by densitometry (Molecular Analyst; Bio-Rad S.A.,
Ivry-sur-Seine, France). The ratios of the band intensities of the PCR
products from the standard RNA and target RNA were plotted against the starting number of standard RNA molecules using a double logarithmic scale. When the ratio equals 1, the number of target RNA molecules is
equivalent to the number of standard RNA molecules.
 |
RESULTS |
Course of infection and weight changes.
To investigate the
role of IFN-
in the pathogenesis of C. parvum, we studied
the susceptibility to infection of C57BL/6 mice which recover from
infection and C57BL/6-GKO mice which do not recover (33).
In C57BL/6 adult mice, under our experimental conditions, no oocysts
could be detected in the feces of mice inoculated with 106
oocysts of C. parvum. In neonatal mice, the oocyst
production in intestines were first detected 4 days postinfection
(p.i.), increased until 9 days p.i., and then declined until no oocysts were detected under our experimental conditions by day 20 (Fig. 1A). The infected neonatal mice had a
lower level of growth than the controls. The difference in weight was
maintained until 30 days p.i. despite the clearance of infection (Fig.
1D). GKO neonates did not survive after 5 days p.i. when they were
grown with their mother, because the dams became infected and did not
feed their young. For GKO neonates cross-fostered onto C57BL/6 mothers,
the course of infection and the weight time course were similar to those of wild-type C57BL/6 neonates in the first 6 days after inoculation (Fig. 1B). However, despite the fact that neonates were
suckled normally, 80% of GKO neonatal mice died between days 7 and
9 p.i. During this period, the surviving mice were moribund and
continued to lose weight, and none survived more than 10 days p.i.
(Fig. 1E).

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 1.
Course of infection and weight changes in C57BL/6 and
GKO neonatal mice and GKO adult mice infected with 106
oocysts of C. parvum. Each point represents the mean ± the standard deviation of the number of oocysts (upper panels) and of
the weight (lower panels). Parasite loads in the intestine of infected
C57BL/6 neonatal mice (n = 5) (A) and GKO neonatal mice
(n = 5) (B) are shown. (C) Oocyst excretion in GKO mice
(n = 21 to 33 through day 9; n = 6
through day 32). (D) Weight changes in infected ( ) (n = 6) and control ( ) (n = 7 to 11) C57BL/6
neonatal mice. (E) Weight changes in infected ( ) (n = 23 to 46 through day 8; n = 6 through day 9) and
control ( ) (n = 20) GKO neonatal mice. (F) Weight
changes in control ( ) (n = 6) and infected ( )
(n = 10 to 15 through day 9; n = 3
through day 23) GKO mice. Arrows indicate the time point at which GKO
neonates began to die.
|
|
For the GKO adult mice, excretion of oocysts in feces was first
detected 3 days after inoculation and reached maximum excretion by day
6 p.i. The magnitude of oocyst shedding was maintained until death
or euthanasia of the mice (Fig. 1C). Body weights of the infected mice
decreased when oocyst shedding was at maximum and until 9 days p.i.
Afterwards, the GKO mice gained back some weight despite the chronic
infection; however, the weight difference persisted at least until the
end of the experiment (30 days p.i.) (Fig. 1F).
Th1 and Th2 cytokines and iNOS mRNA expression is up-regulated
during infection.
Control of parasitic infections is generally
dependent on the production of cytokines; we therefore studied the
expression of IFN-
, IL-12p40, IL-18, and iNOS mRNA for the Th1
pattern and IL-4 and IL-10 mRNA for the Th2 pattern. To analyze
cytokine expression during C. parvum infection, two time
points were selected: 4 and 9 days p.i. for the beginning and the
maximum of oocyst production, respectively, because of the course of
infection in wild-type neonates and GKO adult mice. We first used
qualitative RT-PCR to screen the cytokines that were regulated during
infection and may therefore play a role in the resolution of
cryptosporidiosis. Thereafter, in order to measure the levels of
cytokine expression, we performed quantitative RT-PCR on total RNA
pooled from the different mice.
In C57BL/6 adult mice, there were no modifications of the cytokine
levels, probably due to the absence of significant infection. Figure
2 shows the individual cytokine response
in wild-type neonates and in GKO (neonate and adult) mice. In neonatal
mice, both Th1 and Th2 mRNA expression increased by days 4 and 9 p.i. in the ileum, except for IL-18, for which the expression levels
did not change. This up-regulation of mRNA expression was markedly
elevated at day 9 p.i., with a strong Th1-type cytokine expression
(900× for IFN-
and 666× for iNOS mRNA), although IFN-
mRNA was
already increased by 250-fold at 4 days p.i. (Table
1), suggesting that IFN-
may be one of
the first cytokines involved in the response to C. parvum.

View larger version (74K):
[in this window]
[in a new window]
|
FIG. 2.
Qualitative RT-PCR amplification of Th1 and Th2
cytokines and iNOS mRNA of C. parvum-infected C57BL/6 and
GKO neonatal mice and GKO adult mice. mRNA was extracted from the ilea
of mice, as reported in Materials and Methods. The data shown are the
results from individual mice. Thirty-five amplification cycles were
performed, except for -actin (28 cycles) and iNOS (GKO adult mice)
(33 cycles). Asterisk, ileum extracted from moribund GKO
neonates.
|
|
Although basal levels of mRNA were in some cases different between GKO
neonates and GKO adult mice, the extent of the cytokine mRNA response
was similar at day 4 p.i. In the absence of IFN-
, the
expression of the Th2-type cytokines, IL-4 and IL-10, increased as in
wild-type neonates, whereas iNOS mRNA up-regulation was weak. By day
9 p.i., when the levels of iNOS (5.4×) and IL-12p40 mRNA remained
weak or undetectable in GKO adult mice despite the extent of the
infection, mRNA levels in GKO neonates were increased (143× for
iNOS and 25× for IL-12p40). It should be noted that the cytokine
response in GKO neonates at day 9 p.i. was studied with moribund
mice, which manifested acute injury of the villi (Fig. 3C and
D).

View larger version (122K):
[in this window]
[in a new window]
|
FIG. 3.
Histological analysis of hematoxylin- and eosin-stained
section of ileum from wild-type neonates (A and B) (magnification,
×800), GKO neonates (C and D) (magnification, ×300 and ×800,
respectively), and GKO adult mice (E and F) (magnification, ×300).
Panels A and E show ileum from control mice. Panels B, C, D, and E show
ileum from mice infected for 9 days with C. parvum (C. parvum organisms are indicated by arrowheads). Note in panels C
and D the detachment of enterocytes at the tip of the villi and the
infiltration of the lamina propria with bacteria (arrow).
|
|
mRNA expression of proinflammatory cytokines is upregulated
during infection.
Among a spectrum of pathological changes
observed in the intestine after C. parvum infection, mucosal
inflammation with neutrophils and mononuclear infiltrates in the lamina
propria is frequently observed. In wild-type neonates the inflammation
was moderate (Fig. 3B), whereas in GKO adult mice, which were more
infected, the villi were heavily infiltrated by inflammatory cells
(Fig. 3F). In GKO neonates still alive at day 9 p.i., C. parvum infection induced ileal mucosa injury, with a detachment of
enterocytes at the tip of the villi (Fig. 3C and D). TNF-
and
IL-1
are the main cytokines produced at the inflammatory sites and
subsequently induce mRNA expression of GM-CSF and IL-6. To investigate
the inflammatory response, we studied mRNA expression of these
proinflammatory cytokines in the ilea of C. parvum-infected
mice. The mRNA expression of TNF-
, IL-1
, and IL-6 increased
moderately in the wild-type neonatal mice 4 and 9 days after infection
(Fig. 4; Table
2). In the GKO mice (adults and
neonates), IL-1
and IL-6 mRNA levels increased by day 4 p.i.,
at which time the TNF-
mRNA was not up-regulated. At day 9 p.i., in surviving GKO neonates, IL-6, GM-CSF, TNF-
, and mainly
IL-1
mRNA levels were higher than for the wild-type neonates. The
strong overexpression of proinflammatory cytokines was probably due to
the destruction of the ileal epithelium. Therefore, the immune response
at this time point may not reflect only the immune response to C. parvum infection. By day 9 p.i., in the GKO adult mice which
presented nondestructive inflammation of the intestine, GM-CSF, IL-6,
and IL-1
mRNA were overexpressed, whereas TNF-
mRNA was still not
up-regulated, despite significant infection.

View larger version (86K):
[in this window]
[in a new window]
|
FIG. 4.
Qualitative RT-PCR amplification of the mRNA of
inflammatory cytokines of C. parvum-infected C57BL/6 and GKO
neonatal mice and GKO adult mice. mRNA was extracted from the ilea of
mice, as reported in Materials and Methods. The data shown are the
results from individual mice. Thirty-three amplification cycles were
performed, except for -actin (28 cycles) and TNF- (35 cycles).
Asterisk, ileum extracted from moribund GKO neonates.
|
|
Exogenous TNF-
injections in GKO mice decrease oocyst
shedding.
To investigate the role of TNF-
in the development of
cryptosporidiosis, murine recombinant TNF-
was administrated
repetitively by the intraperitoneal route in infected GKO mice. Daily
C. parvum oocyst excretion was measured individually to
determine the severity of infection. From day 3 p.i.,
TNF-
-treated mice shed significantly fewer oocysts than controls
(Fig. 5). After 7 days, at which point the last injection of TNF-
had been performed 3 days earlier, there
was no longer any difference in oocyst excretion.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 5.
TNF- decreases the shedding of oocysts in C. parvum-infected GKO mice. Ten-week-old mice were infected with
105 oocysts of C. parvum and received repeated
intraperitoneal injections of murine rTNF- (6.5 µg/kg) at days 0, 1, 2, and 4. This graph represents the results of two experiments. Each
experiment was performed with four mice per group, and the results were
individually significant. The percentages represent the reduction of
oocyst shedding after TNF- treatment. Significant differences were
observed (double asterisk, P < 0.01; single asterisk,
P < 0.05 [Mann-Whitney U test]).
|
|
 |
DISCUSSION |
The role of IFN-
in enhancing resistance to C. parvum was clearly demonstrated by several groups using
administration of neutralizing IFN-
antibody or GKO mice (6,
22, 35). Recent findings showed that BALB/c-GKO mice were able
to clear the parasite within 2 weeks after infection, suggesting that
in the absence of IFN-
, other mechanisms can lead to protection in
BALB/c mice (38). In chronically infected adult
C57BL/6-GKO mice, these mechanisms, if they exist, are not sufficient
to eliminate the infection. C57BL/6 mouse healing is therefore
dependent on the presence of IFN-
, but the way in which IFN-
has
its protective effect still needs to be clarified.
In this study, we investigated the effect of IFN-
on other cytokines
that could play a role in the resolution of infection using C57BL/6
neonates and neonatal and adult GKO mice. The balance between a Th1 and
Th2 cytokine response often regulates the outcome of infection with
many organisms (15). C. parvum infection of wild-type neonates induces strong up-regulation of IFN-
, iNOS, and
IL-12p40 mRNA expression in the mucosa, whereas in the adult GKO mice
mRNA expression of IL-12p40 and iNOS was not increased or was poorly
increased. Culshaw et al. previously reported that intraepithelial
lymphocytes (IEL) could be a source of IFN-
that conferred
protection against cryptosporidiosis in mice (8). Both
IL-12 (35) and NO (19) have been shown to
also participate in the clearance of infection. Urban et al. showed
that the treatment of mice with IL-12 before experimental inoculation
prevented or greatly reduced the severity of the infection via an
IFN-
-dependent mechanism. Our data show that the increase of IFN-
mRNA expression preceded the maximum level of IL-12p40 mRNA expression,
suggesting that IL-12 may not be the only cytokine participating in the
initial increase in IFN-
mRNA expression in the mucosa. IL-18, first designated IGIF (interferon gamma inducing factor), is another strong
inductor of IFN-
and is expressed in intestinal epithelial cells
(31). However, although a low level of mRNA expression was
measured by RT-PCR, we did not observe any increase of the expression
level during the infection. To release the IL-18 mature form, pro-IL-18
needs to be cleaved by a protease, ICE or caspase 1 (10).
IL-18 is unlikely to play a role in the initial IFN-
response after
C. parvum infection, since injection of caspase 1 inhibitor
in neonates did not modify the IFN-
mRNA response (data not shown).
A recent study by Leitch and He demonstrated a modest but significant
role for reactive nitrogen produced by epithelial cells in limiting the
severity and course of infection in neonatal mice (19).
Our results confirm the increased expression of iNOS in the ileum
following infection of neonatal mice. Our results also extend those
findings by demonstrating that IFN-
is most probably responsible for
the majority of iNOS mRNA up-regulation after infection. In fact, in
the absence of IFN-
, GKO neonates did not up-regulate iNOS mRNA
levels compared to wild-type neonates by day 4 p.i. In addition,
in adult GKO mice, iNOS mRNA expression was not strongly increased
despite significant infection. The strong up-regulation of iNOS mRNA
observed in surviving GKO neonates at day 9 p.i. was probably due
to the presence of bacteria in the injured mucosa. Several in vitro
studies reported that bacterial infections induce strong and rapid
up-regulation of iNOS mRNA levels in intestinal epithelial cells
(28, 36). Moreover, in vitro stimulation of epithelial
cells with IFN-
increased iNOS mRNA levels and NO production,
whereas C. parvum infection alone did not (unpublished data).
In both wild-type neonates and GKO (neonatal and adult) mice, mRNA
expression levels for IL-4 and IL-10 increased during infection. In
IFN-
-deficient mice, C. parvum infection did not result
in a shift to a higher level of Th2 cytokine mRNA expression, as observed for other infectious agents like herpesvirus or influenza virus (5, 12). It was assumed that the increased level of IL-4 mRNA observed in our study with infected neonatal and knockout (KO) mice was produced by intraepithelial lymphocytes, as shown by
Aguirre et al. (2). The role of IL-4 in the termination of
infection was demonstrated using antibody depletion and C57BL/6 IL-4 KO
mice. However, increased expression of IL-10 has never been observed in
murine or bovine mucosa infected by C. parvum, and its role
in protection has not been demonstrated. Thus, the role of IL-10 in the
resolution of C. parvum infection deserves to be
investigated. However, the presence of IL-4 and IL-10 in the mucosa
during the infection of adult C57BL/6-GKO mice did not prevent the
chronic infection, suggesting that in the C57BL/6 mice, the Th1
cytokine response is indispensable for the clearance of the parasite.
C. parvum infection results in mucosal inflammation of the
intestine with infiltration of inflammatory cells, such as monocytes and neutrophils (11). The extent of the inflammation in
the mucosa is generally related to the severity of infection. Members of our laboratory and others have previously shown that C. parvum-infected epithelial cells can participate in mucosal
inflammation by producing C-X-C chemokines (IL-8 and Gro-
)
(18, 29). Proinflammatory cytokines like IL-1
and
TNF-
, produced by many different cell types, can induce and amplify
the secretion of various chemokines and therefore promote the
recruitment of inflammatory cells in the mucosa. Our finding that
IL-1
and TNF-
transcripts were produced in response to C. parvum infection in wild-type neonates confirms the findings of
Seydel et al. using the human intestinal xenograft model
(29). Our results extend those findings by demonstrating that IL-6 and GM-CSF transcripts are also produced in response to
C. parvum infection. In the complete absence of IFN-
,
C. parvum infection resulted in a more extensive
inflammation of the ileum than in the wild-type neonates. In adult GKO
mice, expression of the proinflammatory cytokine was elevated except
for TNF-
mRNA, which was undetectable despite severe infection.
Moreover, TNF-
mRNA up-regulation at day 4 p.i. was lower in
GKO neonates (1.1×) than in wild-type neonates (5×). The recent study
of Smith et al. (30), who demonstrated the absence of
TNF-
mRNA in the splenocytes of C57BL/6-GKO mice after infection
with C. parvum, is consistent with our results with GKO
adult mice. It seems likely, therefore, that IFN-
could contribute
to the overexpression of TNF-
mRNA observed in the ileum during
C. parvum infection. In this study, we demonstrated that
exogenous TNF-
significantly decreased excretion of oocysts in
infected adult C57BL/6-GKO mice which did not overexpress this
proinflammatory cytokine, suggesting that TNF-
could participate in
protection against C. parvum. Despite increased expression
of TNF-
mRNA levels by moribund GKO neonates at day 9 p.i.,
none survived more than 10 days p.i. We hypothesize that the increased
TNF-
mRNA levels in moribund mice were probably not related only to
C. parvum infection and, in any case, the TNF-
would have
been produced too late to have an effect on the extent of infection,
since at this time point there was already extensive damage to the
intestine. The role of TNF-
in cryptosporidiosis had already been
studied with mice, but the injection of neutralizing TNF-
-specific
antibody did not affect the course of infection (6, 21).
The discrepancy between these results and our new findings that TNF-
can participate in protection may be due to the presence of IFN-
in
mice, which may mask any ameliorating effects of TNF-
. Furthermore,
it should be emphasized that the mouse strain can have a large effect
on the outcome of infection. Smith et al. showed that an increase of
TNF-
mRNA occurs in the splenocytes of infected BALB/c-GKO mice,
contrary to what is observed in C57BL/6-GKO mice (30). The
fact that the BALB/c-GKO strain can resolve infection is in favor of a
role of TNF-
in the resolution of cryptosporidiosis. Moreover, the
role of TNF-
in the control of infection has already been
demonstrated for leishmania (32, 37) and Trichuris
muris (4) disease. Many different cell types in the
mucosa can release this cytokine, including IEL, which are in close
contact with epithelial cells. TNF-
can be chemotactic and activate
inflammatory cells and IEL. Moreover, TNF-
can induce the death of
infected or senescent epithelial cells by apoptosis (13).
We recently showed that the infection of intestinal epithelial cells by
C. parvum induced apoptosis (20, 26); however,
the involvement of TNF-
in this mechanism remains to be demonstrated
in vivo.
In conclusion, the mucosal immune response to C. parvum in
C57BL/6 neonatal and GKO mice demonstrates a concomitant Th1 and Th2
cytokine mRNA expression, with a crucial role for IFN-
in the
resolution of the infection. IFN-
acts most probably via more than
one single mechanism. IL-12 and NO have been reported to participate in
the protection of mice against C. parvum. In this study, we
showed that IFN-
facilitates the up-regulation of IL-12, iNOS, and
TNF-
mRNA expression in the intestinal mucosa after C. parvum infection. The injection of exogenous TNF-
in C57BL/6-GKO mice, which significantly decreased oocyst shedding, suggests that this cytokine may take part in the IFN-
-mediated protective immune response.
 |
ACKNOWLEDGMENTS |
We thank Geneviève Fort for technical help in oocyst
preparation, Sébastien Lavilatte for mice breeding, and David
Ojcius (Institut Pasteur, Paris, France) for critical reviewing of the manuscript and for helpful discussion and encouragements. We are also
very grateful to Martin Kagnoff (UCSD, San Diego, Calif.) for kindly
providing plasmids pMCQ1, pMCQ2, pMCQ3, pMCQ4, and pCpNOSQ1.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratoire de
Protozoologie, Unité de Pathologie Aviaire et de Parasitologie,
INRA de Tours, 37380 Nouzilly, France. Phone: (33) 02 47 42 77 67. Fax:
(33) 02 47 42 77 45. E-mail: slacroix{at}tours.inra.fr.
Editor:
J. M. Mansfield
 |
REFERENCES |
| 1.
|
Aguirre, S. A.,
P. H. Mason, and L. E. Perryman.
1994.
Susceptibility of major histocompatibility complex (MHC) class I- and MHC class II-deficient mice to Cryptosporidium parvum infection.
Infect. Immun.
62:697-699[Abstract/Free Full Text].
|
| 2.
|
Aguirre, S. A.,
L. E. Perryman,
W. C. Davis, and T. C. McGuire.
1998.
IL-4 protects adult C57BL/6 mice from prolonged Cryptosporidium parvum infection: analysis of CD4+ +IFN- + and CD4+ +IL-4+ lymphocytes in gut-associated lymphoid tissue during resolution of infection.
J. Immunol.
161:1891-1900[Abstract/Free Full Text].
|
| 3.
|
Arnaud-Battandier, F.,
M. Naciri,
A. Fisher,
C. Ricour,
C. Griscelli, and P. Yvore.
1982.
Intestinal cryptosporidiosis: a new cause of human diarrhoea.
Gastroenterol. Clin. Biol.
6:1045-1046[Medline]. (In French.)
|
| 4.
|
Artis, D.,
N. E. Humphreys,
A. J. Bancroft,
N. J. Rothwell,
C. S. Potten, and R. K. Grencis.
1999.
Tumor necrosis factor is a critical component of interleukin 13-mediated protective T helper cell type 2 responses during helminth infection.
J. Exp. Med.
190:953-962[Abstract/Free Full Text].
|
| 5.
|
Bouley, D. M.,
S. Kanangat,
W. Wire, and B. T. Rouse.
1995.
Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN- knockout mice.
J. Immunol.
155:3964-3971[Abstract].
|
| 6.
|
Chen, W. X.,
J. A. Harp,
A. G. Harmsen, and E. A. Havell.
1993.
Gamma interferon functions in resistance to Cryptosporidium parvum infection in severe combined immunodeficient mice.
Infect. Immun.
61:3548-3551[Abstract/Free Full Text].
|
| 7.
|
Cosyns, M.,
S. Tsirkin,
M. Jones,
R. Flavell,
H. Kikutani, and A. R. Hayward.
1998.
Requirement for CD40-CD40 ligand interaction for elimination of Cryptosporidium parvum from mice.
Infect. Immun.
66:603-607[Abstract/Free Full Text].
|
| 8.
|
Culshaw, R. J.,
G. J. Bancroft, and V. McDonald.
1997.
Gut intraepithelial lymphocytes induce immunity against Cryptosporidium infection through a mechanism involving gamma interferon production.
Infect. Immun.
65:3074-3079[Abstract].
|
| 9.
|
Eckmann, L.,
J. Fierer, and M. F. Kagnoff.
1996.
Genetically resistant (Ityr) and susceptible (Itys) congenic mouse strains show similar cytokine responses following infection with Salmonella dublin.
J. Immunol.
156:2894-2900[Abstract].
|
| 10.
|
Fantuzzi, G., and C. A. Dinarello.
1999.
Interleukin-18 and interleukin-1 : two cytokine substrates for ICE (caspase-1).
J. Clin. Immunol.
19:1-11[CrossRef][Medline].
|
| 11.
|
Genta, R. M.,
C. L. Chappell,
A. C. White, Jr.,
K. T. Kimball, and R. W. Goodgame.
1993.
Duodenal morphology and intensity of infection in AIDS-related intestinal cryptosporidiosis.
Gastroenterology
105:1769-1775[Medline].
|
| 12.
|
Graham, M. B.,
D. K. Dalton,
D. Giltinan,
V. L. Braciale,
T. A. Stewart, and T. J. Braciale.
1993.
Response to influenza infection in mice with a targeted disruption in the interferon gene.
J. Exp. Med.
178:1725-1732[Abstract/Free Full Text].
|
| 13.
|
Guy-Grand, D.,
J. P. DiSanto,
P. Henchoz,
M. Malassis-Seris, and P. Vassalli.
1998.
Small bowel enteropathy: role of intraepithelial lymphocytes and of cytokines (IL-12, IFN- , TNF) in the induction of epithelial cell death and renewal.
Eur. J. Immunol.
28:730-744[CrossRef][Medline].
|
| 14.
|
Harp, J. A., and R. E. Sacco.
1996.
Development of cellular immune functions in neonatal to weanling mice: relationship to Cryptosporidium parvum infection.
J. Parasitol.
82:245-249[CrossRef][Medline].
|
| 15.
|
Infante-Duarte, C., and T. Kamradt.
1999.
Th1/Th2 balance in infection.
Springer Semin. Immunopathol.
21:317-338[Medline].
|
| 16.
|
Jung, H. C.,
L. Eckmann,
S. K. Yang,
A. Panja,
J. Fierer,
E. Morzycka-Wroblewska, and M. F. Kagnoff.
1995.
A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.
J. Clin. Investig.
95:55-65.
|
| 17.
|
Kuhls, T. L.,
D. A. Mosier,
V. L. Abrams,
D. L. Crawford, and R. A. Greenfield.
1994.
Inability of interferon-gamma and aminoguanidine to alter Cryptosporidium parvum infection in mice with severe combined immunodeficiency.
J. Parasitol.
80:480-485[CrossRef][Medline].
|
| 18.
|
Laurent, F.,
L. Eckmann,
T. C. Savidge,
G. Morgan,
C. Theodos,
M. Naciri, and M. F. Kagnoff.
1997.
Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines.
Infect. Immun.
65:5067-5073[Abstract].
|
| 19.
|
Leitch, G. J., and Q. He.
1999.
Reactive nitrogen and oxygen species ameliorate experimental cryptosporidiosis in the neonatal BALB/c mouse model.
Infect. Immun.
67:5885-5891[Abstract/Free Full Text].
|
| 20.
|
McCole, D. F.,
L. Eckmann,
F. Laurent, and M. F. Kagnoff.
2000.
Intestinal epithelial cell apoptosis following Cryptosporidium parvum infection.
Infect. Immun.
68:1710-1713[Abstract/Free Full Text].
|
| 21.
|
McDonald, V.,
R. Deer,
S. Uni,
M. Iseki, and G. J. Bancroft.
1992.
Immune responses to Cryptosporidium muris and Cryptosporidium parvum in adult immunocompetent or immunocompromised (nude and SCID) mice.
Infect. Immun.
60:3325-3331[Abstract/Free Full Text].
|
| 22.
|
McDonald, V.,
H. A. Robinson,
J. P. Kelly, and G. J. Bancroft.
1994.
Cryptosporidium muris in adult mice: adoptive transfer of immunity and protective roles of CD4 versus CD8 cells.
Infect. Immun.
62:2289-2294[Abstract/Free Full Text].
|
| 23.
|
Mead, J. R.,
M. J. Arrowood,
R. W. Sidwell, and M. C. Healey.
1991.
Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice.
J. Infect. Dis.
163:1297-1304[Medline].
|
| 24.
|
Mead, J. R., and X. You.
1998.
Susceptibility differences to Cryptosporidium parvum infection in two strains of gamma interferon knockout mice.
J. Parasitol.
84:1045-1048[CrossRef][Medline].
|
| 25.
|
Novak, S. M., and C. R. Sterling.
1991.
Susceptibility dynamics in neonatal BALB/c mice infected with Cryptosporidium parvum.
J. Protozool.
38:102S-104S.
|
| 26.
|
Ojcius, D. M.,
J. L. Perfettini,
A. Bonnin, and F. Laurent.
1999.
Caspase-dependent apoptosis during infection with Cryptosporidium parvum.
Microbes Infect.
1:1163-1168[CrossRef][Medline].
|
| 27.
|
Rehg, J. E.
1996.
Effect of interferon- in experimental Cryptosporidium parvum infection.
J. Infect. Dis.
174:229-232[Medline].
|
| 28.
|
Salzman, A. L.,
T. Eaves-Pyles,
S. C. Linn,
A. G. Denenberg, and C. Szabo.
1998.
Bacterial induction of inducible nitric oxide synthase in cultured human intestinal epithelial cells.
Gastroenterology
114:93-102[CrossRef][Medline].
|
| 29.
|
Seydel, K. B.,
T. Zhang,
G. A. Champion,
C. Fichtenbaum,
P. E. Swanson,
S. Tzipori,
J. K. Griffiths, and S. L. Stanley, Jr.
1998.
Cryptosporidium parvum infection of human intestinal xenografts in SCID mice induces production of human tumor necrosis factor alpha and interleukin-8.
Infect. Immun.
66:2379-2382[Abstract/Free Full Text].
|
| 30.
|
Smith, L. M.,
M. T. Bonafonte, and J. R. Mead.
2000.
Cytokine expression and specific lymphocyte proliferation in two strains of Cryptosporidium parvum-infected -interferon knockout mice.
J. Parasitol.
86:300-307[CrossRef][Medline].
|
| 31.
|
Takeuchi, M.,
Y. Nishizaki,
O. Sano,
T. Ohta,
M. Ikeda, and M. Kurimoto.
1997.
Immunohistochemical and immuno-electron-microscopic detection of interferon- -inducing factor ("interleukin-18") in mouse intestinal epithelial cells.
Cell Tissue Res.
289:499-503[CrossRef][Medline].
|
| 32.
|
Taylor, A. P., and H. W. Murray.
1997.
Intracellular antimicrobial activity in the absence of interferon- : effect of interleukin-12 in experimental visceral leishmaniasis in interferon- gene-disrupted mice.
J. Exp. Med.
185:1231-1239[Abstract/Free Full Text].
|
| 33.
|
Theodos, C. M.,
K. L. Sullivan,
J. K. Griffiths, and S. Tzipori.
1997.
Profiles of healing and nonhealing Cryptosporidium parvum infection in C57BL/6 mice with functional B and T lymphocytes: the extent of gamma interferon modulation determines the outcome of infection.
Infect. Immun.
65:4761-4769[Abstract].
|
| 34.
|
Ungar, B. L. P.,
T. C. Kao,
J. A. Burris, and F. D. Finkelman.
1991.
Cryptosporidium infection in an adult mouse model: independent roles for IFN- and CD4+ T lymphocytes in protective immunity.
J. Immunol.
147:1014-1022[Abstract].
|
| 35.
|
Urban, J. F., Jr.,
R. Fayer,
S. Chen,
W. C. Gause,
M. K. Gately, and F. D. Finkelman.
1996.
IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum.
J. Immunol.
156:263-268[Abstract].
|
| 36.
|
Witthoft, T.,
L. Eckmann,
J. M. Kim, and M. F. Kagnoff.
1998.
Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells.
Am. J. Physiol.
275:G564-G571[Abstract/Free Full Text].
|
| 37.
|
Xu, D.,
S. J. McSorley,
L. Tetley,
S. Chatfield,
G. Dougan,
W. L. Chan,
A. Satoskar,
J. R. David, and F. Y. Liew.
1998.
Protective effect on Leishmania major infection of migration inhibitory factor, TNF- , and IFN- administered orally via attenuated Salmonella typhimurium.
J. Immunol.
160:1285-1289[Abstract/Free Full Text].
|
| 38.
|
You, X., and J. R. Mead.
1998.
Characterization of experimental Cryptosporidium parvum infection in IFN- knockout mice.
Parasitology
117:525-531.
|
Infection and Immunity, March 2001, p. 1635-1642, Vol. 69, No. 3
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.3.1635-1642.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Takeuchi, D., Jones, V. C., Kobayashi, M., Suzuki, F.
(2008). Cooperative Role of Macrophages and Neutrophils in Host Antiprotozoan Resistance in Mice Acutely Infected with Cryptosporidium parvum. Infect. Immun.
76: 3657-3663
[Abstract]
[Full Text]
-
Pantenburg, B., Dann, S. M., Wang, H.-C., Robinson, P., Castellanos-Gonzalez, A., Lewis, D. E., White, A. C. Jr.
(2008). Intestinal Immune Response to Human Cryptosporidium sp. Infection. Infect. Immun.
76: 23-29
[Full Text]
-
Lean, I-S., Lacroix-Lamande, S., Laurent, F., McDonald, V.
(2006). Role of Tumor Necrosis Factor Alpha in Development of Immunity against Cryptosporidium parvum Infection. Infect. Immun.
74: 4379-4382
[Abstract]
[Full Text]
-
Rogers, K. A., Rogers, A. B., Leav, B. A., Sanchez, A., Vannier, E., Uematsu, S., Akira, S., Golenbock, D., Ward, H. D.
(2006). MyD88-Dependent Pathways Mediate Resistance to Cryptosporidium parvum Infection in Mice. Infect. Immun.
74: 549-556
[Abstract]
[Full Text]
-
Leav, B. A., Yoshida, M., Rogers, K., Cohen, S., Godiwala, N., Blumberg, R. S., Ward, H.
(2005). An Early Intestinal Mucosal Source of Gamma Interferon Is Associated with Resistance to and Control of Cryptosporidium parvum Infection in Mice. Infect. Immun.
73: 8425-8428
[Abstract]
[Full Text]
-
Baishanbo, A., Gargala, G., Delaunay, A., Francois, A., Ballet, J.-J., Favennec, L.
(2005). Infectivity of Cryptosporidium hominis and Cryptosporidium parvum Genotype 2 Isolates in Immunosuppressed Mongolian Gerbils. Infect. Immun.
73: 5252-5255
[Abstract]
[Full Text]
-
Lean, I.-S., McDonald, S. A. C., Bajaj-Elliott, M., Pollok, R. C. G., Farthing, M. J. G., McDonald, V.
(2003). Interleukin-4 and Transforming Growth Factor {beta} Have Opposing Regulatory Effects on Gamma Interferon-Mediated Inhibition of Cryptosporidium parvum Reproduction. Infect. Immun.
71: 4580-4585
[Abstract]
[Full Text]
-
Lacroix-Lamande, S., Mancassola, R., Naciri, M., Laurent, F.
(2002). Role of Gamma Interferon in Chemokine Expression in the Ileum of Mice and in a Murine Intestinal Epithelial Cell Line after Cryptosporidium parvum Infection. Infect. Immun.
70: 2090-2099
[Abstract]
[Full Text]